Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.44 |
| ▸ | CES1 | P23141 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | PGK1 | P00558 | 6/20 | 0.37 |
| ▸ | PGK2 | P07205 | 6/20 | 0.37 |
| ▸ | ALB | P02768 | 1/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29227263 | 0.84 | HDAC1 (0.37) | CES2CES1CA2CA4CA5A | |
| SCHEMBL29227262 | 0.84 | ACHE (0.44) | CES2CES1CA2CA4CA5A | |
| SCHEMBL3889145 | 0.77 | CA2 (0.44) | CES2CES1CA2CA4CA5A | |
| SCHEMBL3403564 | 0.75 | PTK2B (0.42) | CES2CES1CA2CA4CA5A | |
| SCHEMBL28880214 | 0.73 | CES2 (0.45) | CES2CES1CA2CA4CA5A | |
| SCHEMBL30210989 | 0.73 | CES2 (0.45) | CES2CES1CA2CA4CA5A | |
| Phosphoric Acid SCHEMBL28200114 | 0.70 | CES2 (0.44) | CES2CES1CA2CA4CA5A | |
| SCHEMBL20379776 | 0.70 | PTK2B (0.42) | CA2CA4CA5APGK1PGK2 | |
| SCHEMBL25269542 | 0.69 | INPPL1 (0.59) | CES2CES1CA2BCHEKMT2A | |
| SCHEMBL578080 | 0.69 | SMN1; SMN2 (0.57) | CES2CES1PGK1PGK2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113823749-B | Organic electroluminescent device, display panel and display device | 京东方科技集团股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-111312914-B | Quantum dot light-emitting device, preparation method thereof and display device | 京东方科技集团股份有限公司 | 2022-08-26 | — | — | CN | disclosed |
| CN-113823749-A | Organic electroluminescent device, display panel and display device | 京东方科技集团股份有限公司 | 2021-12-21 | — | — | CN | disclosed |
| CN-111312914-A | Quantum dot light-emitting device, preparation method thereof and display device | 京东方科技集团股份有限公司 | 2020-06-19 | — | — | CN | disclosed |
| US-8846978-B2 | Electronic devices comprising novel phosphonic acid surface modifiers | IMPERIAL INNOVATIONS LTD. (GB) | 2014-09-30 | — | — | US | disclosed |
| US-8586208-B2 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-11-19 | — | — | US | disclosed |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | NATIONAL SCIENCE FOUNDATION | 2012-05-10 | — | — | US | disclosed |
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-05-19 | — | — | US | disclosed |
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-05-19 | — | — | US | disclosed |
| WO-2010007081-A1 | STABLE ELECTRODES WITH MODIFIED WORK FUNCTIONS AND METHODS FOR ORGANIC ELECTRONIC DEVICES | GEORGIA TECH RESEARCH CORPORATION (US) | 2010-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110114935-A1 | Stable electrodes with modified work functions and methods for organic electronic devices | EPCAM, EMD, L1CAM | CES2 1243/4885CES1 4467/4885CA2 1177/4885 |
| US-20120114974-A1 | ELECTRONIC DEVICES COMPRISING NOVEL PHOSPHONIC ACID SURFACE MODIFIERS | EFNA1, PHOSPHO1, EPHA6 | CES2 2056/4885CES1 3413/4885CA2 1840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.